secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K/A
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001193125-23-145360
Event type: earnings
Sentiment:  negative
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical corrects Q1 revenue to $10.6M, net loss $9.2M in 8-K/A amendment
------------------------------------------------------------------------------

- Revenue $10.6M (U.S. Dollars); net loss $9.2M, $0.37 per share for quarter ended March 31, 2023.
- Original 8-K transcript erroneously included extraneous tabular data in Australian Dollars; this amendment corrects that error.
- Further details available in Form 10-Q filed May 11, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523145360/0001193125-23-145360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523145360/d489389d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-145360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer